SUBSEQUENT EVENTS |
12 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | NOTE 13 – SUBSEQUENT EVENTS
Shares issued for conversion of Series C Preferred stock
Between July 2026 and August 2026, the Company issued a total of shares of common stock for common stock issuable as of June 30, 2026 which relates to conversion of shares of Series C Preferred stock (see Note 8).
In August 2026, the Company issued an aggregate of shares of its common stock as a result of the conversion of shares of Series C Preferred stock.
In September 2026, the Company issued an aggregate of shares of its common stock as a result of the conversion of shares of Series C Preferred stock.
Shares issued for exercise of Series C Warrants
On August 4, 2026, the Company received aggregate gross proceeds of $500,000 from the exercise of approximately 50 Series C Warrants with an exercise price of $10,000 per share and issued shares of Series C preferred stock.
On August 31, 2026, the Company received aggregate gross proceeds of $1,500,000 from the exercise of approximately 150 Series C Warrants with an exercise price of $10,000 per share and issued shares of Series C preferred stock.
Settlement Payment
In July 2026, the Company paid $ and issued shares of the Company’s common stock valued at $ pursuant to the settlement agreement and release with the Investment Firm (see Note 9).
Repurchase Plan
Between July 2026 and August 2026, the Company repurchased shares of its common stock under the Repurchase Plan for an aggregate purchase price of approximately $, at an average purchase price of $ per share. The shares repurchased are recorded as treasury stock at cost and presented as a reduction of stockholders’ equity in the Company’s consolidated balance sheets.
Shares issued for services
On July 24, 2026, the Company issued an aggregate of shares of common stock to certain officers, an employee, directors and consultants for services rendered in July 2026. Those shares were valued at approximately $ per share or $4,795,000, being the closing price of the stock on the date of grant. |